Interview 20 Mar 2019 Unlocking the Potential of Fast DNA Synthesis While the price and speed of reading DNA have dropped massively, writing DNA fast and affordably still remains a challenge. Philip talked to Sylvain Gariel, COO of the French company DNA Script, who strives to reinvent DNA synthesis. DNA has become a basic necessity in any biology lab. Thanks to new technologies we can now […] March 20, 2019 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 18 Mar 2019 Shares Drop 40% as Allergy Therapeutics Announces Failed Phase III Trial Allergy Therapeutics has revealed that its immunotherapy for birch pollen allergy did not result in a significant symptom improvement when compared to a placebo. As a direct result of the announcement, the shares of Allergy Therapeutics on the London Stock Exchange dropped over 40% within two hours. The phase III trial enrolled 582 people across […] March 18, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 18 Mar 2019 The Search for a Better Biofuel: Can Biotech Deliver? With dire climate change reports landing one after another in 2018 the need for sustainable, scalable, and affordable biofuels to aid in this transition to a more sustainable future has never been greater. Ticking all three boxes is no easy task, but the biotech sector has several promising solutions in development. Producing carbon-neutral fuels from […] March 18, 2019 - 7 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
Startup Scout 15 Mar 2019 This Biotech Wants You to Age Well Age is a risk factor in many diseases, such as cancer and heart disease. The UK biotech Samsara Therapeutics thinks that it can make drugs that can prevent multiple conditions at once by targeting the aging process itself. Mission: To develop drugs that target the biological mechanisms underlying aging. Slowing the aging process seems like […] March 15, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 14 Mar 2019 Microsoft Aims to Make Cell Therapies Cheaper with Artificial Intelligence Microsoft has launched a collaboration with the UK company Oxford BioMedica to use Microsoft’s artificial intelligence technology to make gene and cell therapy manufacturing easier and cheaper. Genetically programming cells and viruses to make cell and gene therapies is not as simple as programming a computer. Organisms have many layers of complexity and unpredictability, sometimes […] March 14, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Mar 2019 Artificial Intelligence Detects Juvenile Arthritis in the Blood Using artificial intelligence, a Belgian research group can diagnose juvenile arthritis from blood samples with almost 90% accuracy and identify different forms of the disease, something that is not currently possible. Juvenile idiopathic arthritis causes joint pain, swelling and stiffness in children under the age of 16. The disease is hard to treat because there […] March 13, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 12 Mar 2019 Stem Cells and Hydrogel Make Potential Osteoarthritis Treatment Scientists from the Netherlands have received a €600,000 grant to test a treatment for osteoarthritis in humans that combines hydrogels and stem cells to help the knee joint heal. In osteoarthritis, the cartilage in joints such as the knees breaks down, causing stiffness and pain. There is no cure at the moment, and most current […] March 12, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 12 Mar 2019 Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis An antibody that blocks the action of a hidden viral protein encoded by our genome shows encouraging signs of slowing down the progression of multiple sclerosis, according to the Swiss biotech GeNeuro which carried out the research. GeNeuro’s monoclonal antibody drug targets the hidden viral protein because it’s linked to the occurrence of multiple sclerosis, […] March 12, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Mar 2019 Danish Biotech to Develop CRISPR-Based Microbiome Treatments SNIPR Biome has raised €43M in Series A funds to develop treatments that precisely target ‘bad’ bacteria using CRISPR gene editing, while keeping the rest of the patient’s microbiome intact. Founded with €2.6M seed investment from the Lundbeck Foundation in 2017, SNIPR Biome was the first exploratory investment for the Danish organisation’s Emerge fund, which […] March 11, 2019 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 11 Mar 2019 Monthly Injection Proves as Good as Daily Pills Against HIV in Phase III Two phase III trials conducted by ViiV Healthcare have concluded that a monthly injection of two anti-HIV drugs is as effective as the standard daily treatment taken by people infected with HIV. The results showed that, after 11 months, the monthly treatment achieved virus suppression levels of over 90% and similar to those of conventional […] March 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 11 Mar 2019 The Three Steps Needed to Fully Automate the Artificial Pancreas New advances in diabetes research are making it possible to develop a fully automated insulin delivery system that can control blood sugar without any input from the patient. This so-called artificial pancreas could be here within the next decade, but there are still three main challenges that scientists have to address to get us there. […] March 11, 2019 - 11 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 11 Mar 2019 The Man Behind Next-Generation Sequencing Nick McCooke shares the story behind the invention of next-generation sequencing at Solexa and his latest adventure in the sequencing world with the company DNA Electronics. Nick McCooke led the pioneer team at Solexa that invented next-generation sequencing, a technology to read DNA at high speed that is nowadays used worldwide and has laid the […] March 11, 2019 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email